Jessica M. Stookey is an associate in the New York office of Cahill Gordon & Reindel LLP, where she focuses her practice on intellectual property litigation.
Jessica's practice is informed by her educational background in biology and laboratory research focused on reproductive endocrinology. Jessica has successfully litigated pharmaceutical patent cases under the Hatch-Waxman Act and has experience litigating in key patent venues.
- Takeda Pharmaceutical Co. Ltd. et al. v. Norwich Pharmaceuticals Inc., No. 20-8966 (d.N.J. Dec. 27, 2022) (trial victory, all asserted claims from nine Orange Book patents covering Takeda’s Vyvanse® were held infringed, not invalid, and enforceable), aff’d, 2023-1374 (Fed. Cir. May 4, 2023)*
- Supernus Pharms. Inc. v. Torrent Pharms. Ltd. et al., Nos. 21-6964, 21-14268 (D.N.J.) (trial victory, all asserted claims from Orange Book patents covering Supernus’s Trokendi XR® were held infringed and valid)*
*Matter handled prior to joining Cahill.